ASCO 2022 Melanoma (American Society of Clinical Oncology) In-Depth Slides: MOASC Spotlight on Oncology I’ll do a brief reminder of standard treatment options and then go over the DREAMseq trial and the RELATIVITY-047 and then if there’s time, if I was adequately caffeinated or something, we’ll also go onto the KEYNOTE-716 in the PRADO clinical … Continue reading ASCO 2022 Melanoma In-Depth Slides: MOASC Spotlight